Nanomal smartphone-like malaria detection device to be field tested one year earlier than scheduled

April 26, 2013

A pioneering mobile device using cutting-edge nanotechnology to rapidly detect malaria infection and drug resistance will be ready for field testing this year, one year ahead of schedule.

The €5.2million (£4million) Nanomal project was launched last year to provide an affordable hand-held to detect and parasites' drug resistance in 15 minutes. It will allow in remote rural areas to deliver effective drug treatments to counter resistance more quickly, potentially saving lives.

The news that the project is a year ahead of schedule comes on World Malaria Day today (25 April), as the warns of the alarming growth of resistance to drug treatments.

Nanomal lead Professor Sanjeev Krishna, from St George's, said: "Recent research suggests there's a real danger that current artemisinin combination therapies could eventually become obsolete, in the same way as other anti-malarials. This risk is worsened when patients presenting with a fever are given anti-malarial drugs without an analysis of the malaria parasites' drug resistance status, or even without a diagnostic test at all, thereby reducing the treatments' effectiveness."

The Nanomal device is being developed by St George's, University of London and Newcastle-based QuantuMDx Group. It will use a range of novel nanotechnologies to rapidly analyse the malarial DNA from a finger-prick of blood. The sample will be processed and a nanowire will detect of interest. This will provide a malaria diagnosis, speciation and drug resistance information in 15 minutes, allowing an effective personalised drug combination to be given immediately. The smartphone-like device will be easy to use; a healthcare worker simply puts the sample into the device, presses a few buttons and waits for the result, making it ideal for use in the field.

QuantuMDx's CEO Elaine Warburton said: "Placing a full malaria screen with drug resistance status in the palm of a health professional's hand will allow instant prescribing of the most effective anti-malaria medication for that patient. Nanomal's rapid, low-cost test will further support the global health challenge to eradicate malaria."

The device aims to provide the same quality of result as a referral laboratory, at a fraction of the time and cost. Each device could cost about the price of a smartphone initially, but may be distributed free in developing countries. A single-test cartridge will be around $13 (£10) initially, but the goal is to reduce this cost to ensure affordability in resource-limited settings.

In addition to improving immediate patient outcomes, the project will allow the researchers to build a better picture of levels of in stricken areas. It will also give them information on population impacts of anti-malarial interventions. The technology could also be adapted afterwards for use with other infectious diseases.

Explore further: Screening effort turns up multiple potential anti-malaria compounds

Related Stories

Simple rapid diagnostic tests for malaria work well

July 6, 2011

When a person living in a malarial area gets a fever, health workers need to know the cause to make absolutely sure they give the right treatment. For many years in sub-Saharan Africa primary health workers have often assumed ...

Chloroquine makes comeback to combat malaria

October 3, 2012

Malaria-drug monitoring over the past 30 years has shown that malaria parasites develop resistance to medicine, and the first signs of resistance to the newest drugs have just been observed. At the same time, resistance monitoring ...

Recommended for you

Zika virus infection alters human and viral RNA

October 20, 2016

Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material. These modifications—chemical tags known as ...

Food-poisoning bacteria may be behind Crohn's disease

October 19, 2016

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn's disease later in life, according to a new study led by researchers at McMaster University.

Neurodevelopmental model of Zika may provide rapid answers

October 19, 2016

A newly published study from researchers working in collaboration with the Regenerative Bioscience Center at the University of Georgia demonstrates fetal death and brain damage in early chick embryos similar to microcephaly—a ...

Scientists uncover new facets of Zika-related birth defects

October 17, 2016

In a study that could one day help eliminate the tragic birth defects caused by Zika virus, scientists from the Florida campus of The Scripps Research Institute (TSRI) have elucidated how the virus attacks the brains of newborns, ...

Ebola drug ZMapp may help, but is not a miracle cure

October 13, 2016

ZMapp, once touted as a miraculous "secret serum" against the deadly Ebola virus, has shown some success but fell short of the bar for effectiveness in a clinical trial, researchers said Wednesday.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.